OMAHA, Neb. — The University of Texas MD Anderson CARTOX Program received accreditation for immune effector cellular therapy by the Foundation for the Accreditation of Cellular Therapy (FACT) at the University of Nebraska Medical Center. The University of Texas MD Anderson CARTOX Program, directed by Elizabeth Shpall, MD, and Sattva S. Neelapu, MD, is the first program to be recognized by FACT for compliance with the new FACT Standards for Immune Effector Cells independent of a bone marrow transplant program. The program received accreditation on April 19, 2018. Read full release

Ask FACT

FAQ

Ask a Peer
FACT Consulting

Accreditation Success Story

The University of Utah Blood and Marrow Transplant Program began at the University Hospital in Salt Lake City in 1990. The program has been FACT accredited for 10 years, and offers suggestions for large programs considering FACT accreditation. Read more